BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 29600480)

  • 21. Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.
    Kaialy W; Nokhodchi A
    Pharm Res; 2013 Feb; 30(2):458-77. PubMed ID: 23070603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.
    Shetty N; Park H; Zemlyanov D; Mangal S; Bhujbal S; Zhou QT
    Int J Pharm; 2018 Jun; 544(1):222-234. PubMed ID: 29678544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation.
    Yu H; Teo J; Chew JW; Hadinoto K
    Int J Pharm; 2016 Feb; 499(1-2):38-46. PubMed ID: 26757148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.
    Meenach SA; Anderson KW; Zach Hilt J; McGarry RC; Mansour HM
    Eur J Pharm Sci; 2013 Jul; 49(4):699-711. PubMed ID: 23707466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction.
    Kozáková J; Altay A; Ždímal V; Mašková L; Sonvico F; Quarta E; Rossi A; Buttini F; Colombo G
    Drug Dev Ind Pharm; 2019 Oct; 45(10):1664-1673. PubMed ID: 31389270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
    Li X; Vogt FG; Hayes D; Mansour HM
    Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of fine solid-crystal suspension with enhanced solubility, stability, and aerosolization performance for dry powder inhalation.
    Lin L; Quan G; Peng T; Huang Z; Singh V; Lu M; Wu C
    Int J Pharm; 2017 Nov; 533(1):84-92. PubMed ID: 28903066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization,
    Acosta MF; Muralidharan P; Grijalva CL; Abrahamson MD; Hayes D; Fineman JR; Black SM; Mansour HM
    Ther Adv Respir Dis; 2021; 15():1753466621998245. PubMed ID: 33719747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spray-dried respirable powders containing bacteriophages for the treatment of pulmonary infections.
    Matinkhoo S; Lynch KH; Dennis JJ; Finlay WH; Vehring R
    J Pharm Sci; 2011 Dec; 100(12):5197-205. PubMed ID: 22020816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.
    Karimi K; Katona G; Csóka I; Ambrus R
    J Pharm Biomed Anal; 2018 Jan; 148():73-79. PubMed ID: 28965047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhalable spray-dried formulation of D-LAK antimicrobial peptides targeting tuberculosis.
    Kwok PC; Grabarek A; Chow MY; Lan Y; Li JC; Casettari L; Mason AJ; Lam JK
    Int J Pharm; 2015 Aug; 491(1-2):367-74. PubMed ID: 26151107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of the extra-fine particle fraction of levofloxacin embedded in excipient matrix formulations for dry powder inhaler using response surface methodology.
    Tse JY; Kadota K; Imakubo T; Uchiyama H; Tozuka Y
    Eur J Pharm Sci; 2021 Jan; 156():105600. PubMed ID: 33075466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of l-Carnitine and l-Carnitine HCL salt for targeted lung treatment of pulmonary hypertension (PH) as inhalation aerosols: Design, comprehensive characterization, in vitro 2D/3D cell cultures, and in vivo MCT-Rat model of PH.
    Acosta MF; Muralidhran P; Abrahamson MD; Grijalva CL; Carver M; Tang H; Klinger C; Fineman JR; Black SM; Mansour HM
    Pulm Pharmacol Ther; 2020 Dec; 65():101998. PubMed ID: 33556627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of excipients on the stability and aerosol performance of salmon calcitonin dry powder inhalers prepared via the spray freeze drying process.
    Poursina N; Vatanara A; Rouini MR; Gilani K; Najafabadi AR
    Acta Pharm; 2016 Jun; 66(2):207-18. PubMed ID: 27279064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections.
    Vandenheuvel D; Singh A; Vandersteegen K; Klumpp J; Lavigne R; Van den Mooter G
    Eur J Pharm Biopharm; 2013 Aug; 84(3):578-82. PubMed ID: 23353012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spray-Congealing and Wet-Sieving as Alternative Processes for Engineering of Inhalation Carrier Particles: Comparison of Surface Properties, Blending and In Vitro Performance.
    Pinto JT; Zellnitz S; Guidi T; Schiaretti F; Schroettner H; Paudel A
    Pharm Res; 2021 Jun; 38(6):1107-1123. PubMed ID: 34114162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of spray freeze drying to theophylline-oxalic acid cocrystal engineering for inhaled dry powder technology.
    Tanaka R; Hattori Y; Otsuka M; Ashizawa K
    Drug Dev Ind Pharm; 2020 Feb; 46(2):179-187. PubMed ID: 31937148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.
    Lu W; Rades T; Rantanen J; Yang M
    Int J Pharm; 2019 Jun; 565():1-8. PubMed ID: 30999050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers.
    Acosta MF; Abrahamson MD; Encinas-Basurto D; Fineman JR; Black SM; Mansour HM
    AAPS J; 2020 Nov; 23(1):2. PubMed ID: 33200330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation.
    Fabio K; Curley K; Guarneri J; Adamo B; Laurenzi B; Grant M; Offord R; Kraft K; Leone-Bay A
    AAPS PharmSciTech; 2015 Dec; 16(6):1299-306. PubMed ID: 25776985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.